Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Hematology. American Society of Hematology. Education Program|December 9, 2022
Novel therapies and combinations in CLL refractory to BTK inhibitors and venetoclaxLydia Scarfò
Blood|January 12, 2023
COVID-19 prophylaxis: half-full or half-empty glass?Lydia Scarfò, Antonio Cuneo
Seminars in Oncology|April 5, 2016
What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challengesLydia Scarfò, Paolo Ghia
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Time to Retire?Lydia Scarfò, Alessandra Tedeschi
Blood|August 4, 2022
CLL and COVID-19: light at the end of the tunnel?Lydia Scarfò, Yair Herishanu
Immunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo Ghia
Current Opinion in Oncology|October 9, 2019
The evolving treatment landscape of chronic lymphocytic leukemiaLuana Schiattone, Paolo Ghia, Lydia Scarfò
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Relevance of Minimal Residual Disease in the Era of Targeted AgentsSilvia Heltai, Paolo Ghia, Lydia Scarfò
Hematology/Oncology Clinics of North America|April 9, 2013
MBL versus CLL: how important is the distinction?Lydia Scarfò, Claudia Fazi, Paolo Ghia
Seminars in Cancer Biology|September 4, 2013
Monoclonal B cell lymphocytosis and "in situ" lymphomaKennosuke Karube, Lydia Scarfò, Elias Campo, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Hematology. American Society of Hematology. Education Program|December 9, 2022
Novel therapies and combinations in CLL refractory to BTK inhibitors and venetoclaxLydia Scarfò
Blood|January 12, 2023
COVID-19 prophylaxis: half-full or half-empty glass?Lydia Scarfò, Antonio Cuneo
Seminars in Oncology|April 5, 2016
What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challengesLydia Scarfò, Paolo Ghia
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Time to Retire?Lydia Scarfò, Alessandra Tedeschi
Blood|August 4, 2022
CLL and COVID-19: light at the end of the tunnel?Lydia Scarfò, Yair Herishanu
Immunology Letters|October 8, 2013
Reprogramming cell death: BCL2 family inhibition in hematological malignanciesLydia Scarfò, Paolo Ghia
Current Opinion in Oncology|October 9, 2019
The evolving treatment landscape of chronic lymphocytic leukemiaLuana Schiattone, Paolo Ghia, Lydia Scarfò
Cancer Journal (Sudbury, Mass.)|November 26, 2019
Relevance of Minimal Residual Disease in the Era of Targeted AgentsSilvia Heltai, Paolo Ghia, Lydia Scarfò
Hematology/Oncology Clinics of North America|April 9, 2013
MBL versus CLL: how important is the distinction?Lydia Scarfò, Claudia Fazi, Paolo Ghia
Seminars in Cancer Biology|September 4, 2013
Monoclonal B cell lymphocytosis and "in situ" lymphomaKennosuke Karube, Lydia Scarfò, Elias Campo, et al.
Pageof 15